# Oliceridine Versus Sufentanil for Blood Pressure Control During Anesthesia Induction in Older Women With Hypertension Undergoing Gynecological Laparoscopic Surgery

Study · id `cardio:ct-nct07871500` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07871500](<https://clinicaltrials.gov/study/NCT07871500>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07871500

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.

## Technical summary

Registry record NCT07871500. Randomized; triple masking; primary purpose prevention. Start 2026-05-15 (actual); primary completion 2026-09-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 134 participants (enrolled count; ClinicalTrials.gov record NCT07871500, source copy `cardio:ctgov-nct07871500-2026-10-13`, retrieved 2026-10-26)
- Started: 2026-05-15 (actual) (ClinicalTrials.gov record NCT07871500, source copy `cardio:ctgov-nct07871500-2026-10-13`, retrieved 2026-10-26)
- Primary completion: 2026-09-15 (actual) (ClinicalTrials.gov record NCT07871500, source copy `cardio:ctgov-nct07871500-2026-10-13`, retrieved 2026-10-26)
- Completion: 2026-09-15 (actual) (ClinicalTrials.gov record NCT07871500, source copy `cardio:ctgov-nct07871500-2026-10-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07871500, source copy `cardio:ctgov-nct07871500-2026-10-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07871500-2026-10-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Oliceridine Versus Sufentanil for Blood Pressure Control During Anesthesia Induction in Older Women With Hypertension Undergoing Gynecological Laparoscopic Surgery
- Condition: Hypotension
- Condition: Hypertension
- Intervention (Drug): Oliceridine
- Intervention (Drug): Sufentanil
- Lead sponsor: Xingguo Xu
- Lead sponsor class: OTHER
- Collaborator: Affiliated Hospital of Nantong University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as a collaborator: Affiliated Hospital of Nantong University (`cardio:org-affiliated-hospital-of-nantong-university`)

## Provenance

Content hash: 72b60c7c07eba18754b39d87e7fb5af5a7bf91515686b91eef077e14461cd96e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
